OPRL1 and Anxiety: Notably, OFQ/N and NOP-R agonists have been shown to attenuate the expression of anxiety-like behaviors and in a manner comparable to that of conventional anxiolytics including diazepam (Jenck et al., 1997, 2000) and alaprozam (Jenck et al., 2000).